Alzheimer's Disease
We are studying a new treatment that may help reduce agitation or confusion in people with Alzheimer's disease. If you or a loved one has Alzheimer's and experiences agitation, you may qualify.
55–90
~ 5 months
Up to $1800
About This Study
This study is testing whether an investigational drug can help reduce certain symptoms in people with Alzheimer's disease. Right now, treatment options are limited, and researchers want to find better choices for patients and their families.
A caregiver or family member must be available to attend visits and help support the participant during the study. The study team will check the participant's health regularly through physical exams, blood and urine tests, heart monitoring, questionnaires, and memory tests. Your safety and comfort are the study team's top priority throughout.
You May Qualify If You
- Diagnosed with Alzheimer's disease
- Are between 55 and 90 years old
- A caregiver who can attend all study visits and help with the study
- The participant lives at home, in a nursing home, assisted living, or long-term care facility
- The participant is able to get around with or without a mobility aid
- Willing to stop certain medications that are not allowed during the study
Interested in This Study?
Contact us to learn more and see if you qualify.